Skip to Content
Søk Menu

SABCS20: Positive results of pembrolizumab in 1L for triple negative breast cancer regardless of chemotherapy partner

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Related

Maren Marie Andreassen

MRI-Based AI Can Detect Responsive Treatment of Breast Cancer After Three Weeks of Therapy

/ Maren Marie Andreassen
BrystkreftNBCN Play the Video 02:20
Adam Brufsky

SABCS 2024: Palbociclib, Abemaciclib, and Ribociclib Can Be Considered Equivalent in the Treatment of HR-Positive/HER2-Negative Metastatic Breast Cancer

/ Adam Brufsky
BrystkreftSABCS24 Play the Video 08:56
Stefania Katrin Finnsdottir

The Need to Improve Compliance with Adjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer

/ Stefanía Katrín Finnsdóttir
BrystkreftNBCN Play the Video 02:45
Minna Tanner

The Approval of New Drugs Should Be Harmonized Across the Nordic Countries

/ Minna Tanner
BrystkreftNBCN Play the Video 03:20
Niklas Loman

We Can Be Proud of What We Have Achieved in the Nordic Breast Cancer Research

/ Niklas Loman
BrystkreftNBCN Play the Video 02:52
Hege Elisabeth Giercksky Russnes

Nordic Pathologists Unite for Advancements in Breast Cancer Care

/ Hege Elisabeth Giercksky Russnes
BrystkreftNBCN Play the Video 01:24
Birgitte Vrou Offersen

New Nordic Breast Cancer Network Boosts Collaboration on Radiotherapy

/ Birgitte Vrou Offersen
BrystkreftNBCN Play the Video 02:17

Towards a Stronger and Unified Nordic Region in Breast Cancer Research and Treatment

/ BestPractice Nordic
BrystkreftNBCN
Hanna Dillekås

Ingen nye studier vil umiddelbart endre brystkreftbehandlingen i Norge, men flere har potensial på sikt

/ Hanna Dillekås
BrystkreftESMO24 Play the Video 01:49
Back to top